Nuaulu ritual regulation of resources, sasi and forest conservation in eastern Indonesia.

Nuaulu (Seram, Maluku, Indonesia) manage forest to provision sacred house building and ritual feasting through a system of protected areas ('sin wesie'), examined here in relation to 'sasi' institutions and scare charms ('matakau') that overlap in their functions. 'Sasi' feature in wider debates about how customary practices might deliver conservation objectives. The paper analyses interconnections between these three forms of regulation in the context of deforestation, social change and the recent history of state management interventions

Retention of fluid and particles in captive tapirs (Tapirus sp.)

The retention of ingesta in the digestive tract is a major characteristic of herbivorous animals. We measured particle and fluid mean retention times (MRT) in 13 lowland tapirs (Tapirus terrestris) and 5 Malayan tapirs (Tapirus indicus) from five zoological institutions on their usual zoo diet and 2 lowland and 4 Malayan tapirs additionally on roughage-only diets (total n of trials = 24) with cobalt-EDTA as fluid and chromium-mordanted fibre (<2mm) as particle markers. MRT for fluid and particles averaged 42 ± 16 h and 55 ± 18 h in lowland and 40 ± 13 h and 56 ± 14 h in Malayan tapirs. In a General Linerar Model, neither Tapir species, body mass nor diet (characteriszed by the proportion of roughage) was significantly related to MRT, but dry matter intake was, with a steep decline in MRT with higher intake levels. Compared to other hindgut fermenters, tapirs have a low defecation frequency, which might be linked to their comparatively low food intake. Their gastrointestinal capacity (in dry matter: 1.63 ± 0.63 % of body mass) is similar to that calculated for horses. A comparison of the difference in fluid and particle MRT in large hindgut fermenters (horses, rhinoceroses, elephants, and the tapirs of this study) show that longer absolute particle MRT are linked to shorter relative fluid MRT, possibly indicating a more thorough ‘washing’ of particulate ingesta with digestive fluids at longer particle MRT. The only outlier to this general pattern, with an exceptionally high difference between fluid and particle MRT, indicating a particularly efficient ingesta washing, is the white rhinoceros (Ceratotherium simum). If possible, results of this study should be compared to findings in tapirs on natural diets

Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity

Background & Aims: Obesity has been associated with changes in the composition and function of the intestinal microbiota. Modulation of the microbiota by antibiotics also alters bile acid and glucose metabolism in mice. Hence, we hypothesized that short term administration of oral antibiotics in humans would affect fecal microbiota composition and subsequently bile acid and glucose metabolism. Methods: In this single blinded randomized controlled trial, 20 male obese subjects with metabolic syndrome were randomized to 7 days of amoxicillin 500 mg t.i.d. or 7 days of vancomycin 500 mg t.i.d. At baseline and after 1 week of therapy, fecal microbiota composition (Human Intestinal Tract Chip phylogenetic microarray), fecal and plasma bile acid concentrations as well as insulin sensitivity (hyperinsulinemic euglycemic clamp using [6,6-H-2(2)]-glucose tracer) were measured. Results: Vancomycin reduced fecal microbial diversity with a decrease of gram-positive bacteria (mainly Firmicutes) and a compensatory increase in gram-negative bacteria (mainly Proteobacteria). Concomitantly, vancomycin decreased fecal secondary bile acids with a simultaneous postprandial increase in primary bile acids in plasma (p Conclusions: Oral administration of vancomycin significantly impacts host physiology by decreasing intestinal microbiota diversity, bile acid dehydroxylation and peripheral insulin sensitivity in subjects with metabolic syndrome. These data show that intestinal microbiota, particularly of the Firmicutes phylum contributes to bile acid and glucose metabolism in humans. This trial is registered at the Dutch Trial Register (NTR2566). (C) 2013 European Association for the Study of the Liver. Published by Elsevier B. V. All rights reserved